Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant Maintenance Study (MODERATO)
NCT00678483Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Apr 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of rimonabant in obesity (2 arms), sponsored by Sanofi. Primary endpoint: Change in weight from baseline to 12 months. Started Apr 2008; status: terminated.
02
Drugs
rimonabant
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00678483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00678483.